Skip to main content

Table 2 Treatment-related characteristics, overall and by sex

From: The association between a detectable HIV viral load and non-communicable diseases comorbidity in HIV positive adults on antiretroviral therapy in Western Cape, South Africa

Treatment-related Characteristics Sample n = 318 (%) Male n = 80 (%) Female n = 238 (%) Chi2 P Value
Duration of ART (years): Median (IQR) 4 (2–7) 3 (2–6) 4 (2–7) 0.09c
0.5–2.5 89 (27) 26 (33) 63 (26)  
2.6–4.0 76 (24) 25 (31) 51 (22) 0.09
4.1–6.0 59 (19) 12 (15) 47 (20)  
  > 6.0 94 (30) 17 (21) 77 (32)  
Most recent Viral load (copies/ml)
Detectable 60 (19) 18 (22) 42 (18) 0.34
Not detectable (LDL/< 40) 258 (81) 62 (78) 196 (82)  
Time since last VL: Median (IQR) (months) 7 (4–11) 5 (3–10) 7 (4–11) 0.21c
Most recent CD4 count (n = 299; inc. 76 males)
Binary Indicator (cells/mm3):
Low (≤350) 92 (31) 35 (46) 57 (25) < 0.001
High (> 350) 207 (69) 41 (54) 166 (75)  
Categorised CD4
Low: 0–299 73 (24) 28 (37) 45 (20) < 0.001
300–449 58 (20) 17 (22) 41 (19)  
450–599 79 (26) 21 (28) 58 (26)  
High: ≥600 89 (30) 10 (13) 79 (35)  
Time since last CD4 measurement: Median (IQR) (months) (n = 299; inc. 76 males) 8 (4–12) 6 (3–11) 8 (4–12) 0.31c
  1. Significant results in italics. c Wilcoxon rank sum test. N = 318 unless otherwise indicated